Every 8-K that PYXUS INTL INC NEW (PYYX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PYYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PYYX filings page.
Pyxus International, Inc. reports the results of its 2026 annual meeting of shareholders held on August 13, 2026. Shareholders elected seven directors—John S. Alphin, Jamie J. Ashton, Patrick J. Bartels, Jr., Robert D. George, Cynthia P. Moehring, J. Pieter Sikkel and Richard J.C. Topping—for one-year terms expiring at the 2027 annual meeting.
Shareholders also ratified the appointment of Deloitte & Touche LLP as independent auditors for the fiscal year ending March 31, 2027, with 20,237,672 votes for and 635 against. In addition, shareholders approved, on an advisory basis, the compensation of the company’s named executive officers, receiving 18,392,358 votes for, 748,737 against and 830 abstentions, with 1,096,382 broker non-votes.
Pyxus International reported first quarter fiscal 2027 results for the period ended June 30, 2026. Sales and other operating revenues were $437.8 million, down from $508.8 million a year earlier, mainly from lower average tobacco prices and shipment timing, particularly in North America.
Gross profit was $61.4 million with a margin of 14.0%, up from 12.9% as regional mix, especially Europe, supported pricing. Operating income was $15.7 million. Net loss attributable to Pyxus narrowed to $7.3 million from $15.8 million, helped by a $5.7 million income tax benefit versus a prior-year tax expense.
Adjusted EBITDA was $27.7 million compared with $29.5 million. Leaf tobacco inventories declined to $1,065.2 million and net debt decreased by $130.9 million to $1,108.7 million, with $175.9 million of cash and no borrowings on the $150.0 million ABL facility. The company maintained full‑year fiscal 2027 guidance for net sales of $2.3–$2.5 billion and Adjusted EBITDA of $210–$240 million.
Pyxus International reported strong fourth-quarter and solid full-year 2026 results, highlighted by record profitability and improved leverage. Q4 sales rose 35.2% year-over-year to $678.2 million, driven by higher leaf sales volumes from Africa and North America, lifting gross profit to $94.4 million and operating income to $43.7 million.
For the year ended March 31, 2026, sales slipped 2.8% to $2.413 billion as lower average pricing offset volume gains, but gross profit improved to $347.7 million and operating income increased to $162.7 million. Net income attributable to Pyxus was $14.6 million, or $0.56 per diluted share, and adjusted EBITDA reached a record $226.7 million.
Liquidity and balance sheet metrics strengthened: Q4 operating cash flow was $310.1 million, adjusted free cash flow was $352.1 million, cash and cash equivalents increased to $134.3 million, and net debt/adjusted EBITDA improved to 3.52x. For fiscal 2027, the company guides to $2.3–$2.5 billion of sales and $210–$240 million of adjusted EBITDA.
Pyxus International reported strong third quarter fiscal 2026 results, highlighted by net income of $16.9 million and adjusted EBITDA of $80.0 million, essentially matching last year’s record third quarter performance. Management reiterated that the company remains on track for one of its strongest years.
Third quarter sales and other operating revenues were $655.8 million, down from $778.3 million, mainly due to shipment timing in Africa and Europe and lower average pricing in South America tied to lower crop purchase costs. Despite lower revenue, gross margin improved to 15.2% from 15.0%, helped by larger South American crops and higher third‑party processing volumes.
For the first three quarters, sales were $1.73 billion, a 12.4% decline from $1.98 billion, while gross margin rose to 14.6% from 13.9%. Tobacco inventory increased to $959.8 million, in line with larger crops, and net debt rose by $199.4 million versus the prior year, with no outstanding borrowings on the $150.0 million ABL facility. Pyxus reaffirmed full‑year fiscal 2026 guidance, targeting net sales of $2.4–$2.6 billion and adjusted EBITDA of $215–$235 million.
Pyxus International, Inc. furnished an 8-K announcing it issued a press release with operating and financial results for the three and six months ended September 30, 2025. The press release is included as Exhibit 99.1.
The company notes the information is furnished, not filed under Section 18 of the Exchange Act. The report lists no securities registered under Section 12(b). The date of the report and press release is November 12, 2025.